Biotest Aktiengesellschaft reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EUR 117.2 million compared to EUR 115.9 million a year ago. Net loss was EUR 20.4 million compared to EUR 4.9 million a year ago.

Basic loss per share from continuing operations was EUR 0.53 compared to EUR 0.13 a year ago.